Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Podcasts
  • Drug Charts
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! RxAdvanced: Diabetes Monitoring & Management program provides pharmacists with the skills needed to effectively advise patients and clinicians on how to use technology and pattern management to achieve improved glycemic control. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment

Treatment

  • Diabetes (905)
    • Blood Glucose Meters (9)
    • Complications (203)
    • Diabetes in Pregnancy (12)
    • Diabetes Meds (86)
    • Drug-Induced Hypo/Hyperglycemia (140)
    • Monitoring (140)
    • Natural Medicines/Supplements (12)
    • Prevention (47)
    • Treatment (376)
      • Alpha-Glucosidase Inhibitors (27)
      • Amylin Agonist (20)
      • Bromocriptine (10)
      • Combination Products (23)
      • Gliptins (85)
      • Glitazones (129)
      • GLP-1 (41)
      • Incretin Enhancers/Mimetics (82)
      • Insulin (197)
      • Meglitinides (46)
      • Metformin (165)
      • SGLT2 Inhibitors (91)
      • Sulfonylureas (131)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (10)
  • Hyperglycemia (39)
  • Hypoglycemia (19)
  • Other (31)
  • Prediabetes (5)
  • Resources (277)
  • Thyroid Disorders (64)
301 - 315 of 376 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: which is the best drug to add to metformin for type 2 diabetes May 2010
Commentary: Avandia and Cardiovascular Safety: Ongoing Review April 2010
Other: Senate Concerns about Avandia April 2010
Article: Ongoing concerns about Avandia (rosiglitazone) April 2010
Commentary: Insulins March 2010
Commentary: New Drug: Victoza (Liraglutide) March 2010
Article: whether Avandia (rosiglitazone) increases heart attack risk March 2010
Article: Metformin or glyburide will be used more for gestational diabetes March 2010
Article: Victoza (VIC-tow-za) will compete with Byetta for type 2 diabetes March 2010
Article: new warnings about Byetta and kidney failure December 2009
Article: new warnings about reports of acute pancreatitis with sitagliptin (Januvia, Janumet) November 2009
Other: Pancreatitis and Byetta (Exenatide) November 2009
Commentary: Januvia (Sitagliptin) and Pancreatitis November 2009
Article: whether a DOUBLE dose of clopidogrel (Plavix) improves outcomes in cardiac patients October 2009
Article: Onglyza (on-GLY-zah), the second "gliptin" for type 2 diabetes September 2009
  • « Prev
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved